IUSV - ETF AI Analysis
Top Page
iShares Core S&P US Value ETF (IUSV)
IUSV, the iShares Core S&P US Value ETF, earns a solid overall rating thanks to strong, high-quality holdings like Apple and Walmart, which bring robust financial performance, growth in services and e-commerce, and supportive long-term business trends. The fund’s rating is held back somewhat by weaker names such as Intel and Procter & Gamble, where valuation concerns, profitability and cash flow challenges, and bearish technical signals add risk. A key risk factor is the meaningful exposure to a few large companies, which can make the ETF’s performance more sensitive to issues in those specific stocks.
IUSV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 27.98B
- Region
- North America
- Expense Ratio
- 0.04%
- Beta
- 0.72
- Issuer
- iShares
- Inception Date
- Jul 24, 2000
- Dividend Yield
- 1.66%
- Asset Class
- Equity
- Index Tracked
- S&P 900 Value
IUSV Summary
The iShares Core S&P US Value ETF (IUSV) is a fund that follows the S&P 900 Value Index, which focuses on U.S. companies that appear cheaper based on things like earnings and dividends. It holds a wide mix of stocks across many sectors, including big names like Apple and Amazon, plus companies such as Exxon Mobil and Walmart. Someone might invest in this ETF to get broad, low-cost exposure to many “value” stocks at once, aiming for long-term growth and diversification. A key risk is that these stocks can still rise and fall with the overall stock market.
How much will it cost me?
The iShares Core S&P US Value ETF (IUSV) has an expense ratio of 0.04%, meaning you’ll pay $0.40 per year for every $1,000 invested. This is lower than average because it’s passively managed, tracking the S&P 900 Value Index rather than relying on active stock picking.
What would affect this ETF?
The iShares Core S&P US Value ETF (IUSV) could benefit from a strong U.S. economy and growth in sectors like technology and financials, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns might negatively impact value stocks, particularly in sectors like consumer cyclical and real estate. Regulatory changes or shifts in market sentiment toward growth stocks could also influence the ETF's performance.
IUSV Top 10 Holdings
IUSV leans heavily on U.S. blue chips, with Apple acting as the main engine, its rising share price giving the fund a clear tech tilt despite the value label. Exxon and Chevron have been steady climbers, helping the energy sleeve pull its weight, while Merck’s strong, steady run adds a defensive health care backbone. On the flip side, Tesla is dragging the fund, and Amazon’s mixed performance isn’t helping much. Overall, this is a U.S.-centric value play with a surprising dose of Big Tech driving the story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 7.92% | $2.21B | $5.01T | 38.80% | 79Outperform |
 AMZN | Amazon | 3.64% | $1.02B | $2.70T | 16.57% | 71Outperform |
 XOM | Exxon Mobil | 2.33% | $649.89M | $735.95B | 61.77% | 74Outperform |
 WMT | Walmart | 1.67% | $467.56M | $942.61B | 11.59% | 78Outperform |
 INTC | Intel | 1.41% | $394.25M | $474.96B | 143.89% | 64Neutral |
 COST | Costco | 1.39% | $387.36M | $438.30B | 6.86% | 72Outperform |
 CVX | Chevron | 1.40% | $392.55M | $444.53B | 48.30% | 71Outperform |
 TSLA | Tesla | 1.20% | $335.46M | $1.40T | -17.27% | 73Outperform |
 PG | Procter & Gamble | 1.17% | $327.08M | $370.12B | 6.52% | 69Neutral |
 UNH | UnitedHealth | 1.14% | $318.19M | $360.32B | 12.55% | 72Outperform |
IUSV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IUSV, the sentiment is Positive. The current price of 113.79 is above the 20-day moving average (MA) of 112.09, above the 50-day MA of 113.13, and above the 200-day MA of 108.21, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 61.01 is Neutral, neither overbought nor oversold. The STOCH value of 84.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IUSV.
IUSV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| IUSV | $113.79 | $126.00(10.73% Upside) | $27.98B | 0.04% | 72Outperform |
 VTI | $374.07 | $464.75(24.24% Upside) | $699.61B | 0.03% | 73Outperform |
 VIG | $241.77 | $279.91(15.78% Upside) | $113.07B | 0.04% | 73Outperform |
 ITOT | $166.08 | $203.97(22.81% Upside) | $97.10B | 0.03% | 73Outperform |
 CGDV | $48.93 | $61.56(25.80% Upside) | $39.18B | 0.33% | 71Outperform |
 DFUV | $56.05 | $66.26(18.21% Upside) | $15.43B | 0.21% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IUSV | iShares Core S&P US Value ETF | 113.79 | 14.65 | 14.77% | |
| VTI | Vanguard Total Stock Market ETF | 374.07 | 46.86 | 14.32% | |
| VIG | Vanguard Dividend Appreciation ETF | 241.77 | 27.98 | 13.09% | |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 166.08 | 20.78 | 14.30% | |
| CGDV | Capital Group Dividend Value ETF | 48.93 | 7.34 | 17.65% | |
| DFUV | Dimensional US Marketwide Value ETF | 56.05 | 11.88 | 26.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.